USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Alcon Pharmaceuticals, Ltd.

USPTO PatentsView assignee record - 20 granted patents across 8 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Alcon ranks #14,446 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 8 technology areas.

#14,446
of 49,997 US assignees by volume
39th percentile
by Innovation Score (31.8/100)
15.7
avg claims per patent
-82%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14446 · Foreign Corporation #14,446 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 20 grants
  • MID-PACK #14,446/49,997
  • PHOTO-FINISH Airgas
  • CPC-NARROW A61F · 8 areas
  • INNOV-THIN 31.8/100
  • CLAIMS-RICH 15.7 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -82% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Airgas, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Alcon’s 31.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Alcon

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Alcon's Innovation Score is 31.8/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Alcon?

Each dot is one of Alcon’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Alcon’s own 15.7 claims/patent is at or below the 17.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Alcon vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 19.919.92020.1 0510152025 Granted patents (volume) Avg claims / patent AirStrip IP Holdings, LLC - 20, 17Airstrip IP Holdi…Airgas, Inc. - 20, 9.6AirgasAkron Brass Company - 20, 17.75Akron BrassAkston Biosciences Corporation - 20, 17.9Akston BiosciencesAleris Rolled Products Germany GmbH - 20, 19.8Aleris Rolled Pro…Allot Ltd. - 20, 21.65AllotAloys F. Dornbracht GmbH & Co. KG - 20, 1Aloys F Dornbrach…Amlogic Co., Limited - 20, 15.6AmlogicAlcon Pharmaceuticals, Ltd. - 20, 15.7Alcon Pharmaceuti…
Alcon vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Alcon's grants concentrate

Alcon Pharmaceuticals, Ltd. is a focused PatentsView assignee: 8 CPC subclasses with 60% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (6 grants) versus a trough of 1 in 2017. By volume, Alcon sits between AirStrip IP Holdings, LLC and Amlogic Co., Limited.

Alcon's three-year grant acceleration

Alcon Pharmaceuticals, Ltd. shows 2 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Alcon's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Alcon holds 20 patents at rank #14,462, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Alcon

By rank, the assignees closest to #14,462 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Alcon's primary technology class.

Alcon's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 20152016201720182019202020232024 1
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Alcon Pharmaceuticals, Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 5 25.0%
2016 3 15.0%
2017 1 5.0%
2018 2 10.0%
2019 6 30.0%
2020 1 5.0%
2023 1 5.0%
2024 1 5.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Alcon Pharmaceuticals, Ltd.'s patent record in context - here's where to go next.

  • Alcon Pharmaceuticals, Ltd.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 60% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #14,446 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Alcon Pharmaceuticals, Ltd. against AirStrip IP Holdings, LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 31.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.